ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
5 clinical trials · Condition
◉ Watch ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer (NCT03131206) | Dana-Farber Cancer Institute | 2017-06-19 |
| Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors (NCT06834074) | Nuvalent Inc. |
Track ALK-Positive Non-Small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.